Skip to Main Content

For further information, see CMDT Part 35-06: Anthrax

KEY FEATURES

Essentials of Diagnosis

  • Epidemiologic setting

    • Exposure to animals or animal hides

    • Exposure to an act of bioterrorism

  • Cutaneous anthrax

    • Black eschar on exposed skin

    • Marked surrounding edema and vesicles

    • Typically painless

  • Inhalational anthrax

    • Nonspecific flu-like symptoms

    • Rapidly progresses to extreme dyspnea and shock

    • Chest radiograph shows mediastinal widening and pleural effusions

General Considerations

  • Naturally occurring anthrax is a disease of sheep, cattle, horses, goats, and swine

  • Bacillus anthracis

    • A gram-positive spore-forming aerobic rod

    • Spores—not vegetative bacteria—are the infectious form of the organism

  • Transmitted to humans from contaminated animals, animal products, or soil by inoculation of broken skin or mucous membranes; by inhalation of aerosolized spores; or, rarely, by ingestion, resulting in cutaneous, inhalational, or gastrointestinal forms of anthrax, respectively

  • Spores germinate into vegetative bacteria that multiply locally in cutaneous and gastrointestinal anthrax but may also disseminate to cause systemic infection

  • Spores entering the lungs are ingested by macrophages and carried via lymphatics to regional lymph nodes, where they germinate

    • The bacteria rapidly multiply within the lymphatics, causing a hemorrhagic lymphadenitis

    • Invasion of the bloodstream can lead to overwhelming sepsis and death

CLINICAL FINDINGS

Symptoms and Signs

Cutaneous anthrax

  • Onset occurs within 2 weeks of exposure

  • Initial lesion is erythematous papule, often on exposed area of skin, that vesiculates, ulcerates, and undergoes necrosis, ultimately progressing to a purple-to-black eschar

  • Eschar is typically painless

  • Surrounding area is edematous and vesicular but not purulent

  • Regional adenopathy, fever, malaise, headache, and nausea and vomiting may occur

  • Infection is usually self-limited

Inhalational anthrax

  • Occurs in two stages, beginning on average 10 days after exposure, but may have a latent onset 6 weeks after exposure

  • Initial stage: Nonspecific viral-like symptoms such as fever, malaise, headache, dyspnea, cough, and congestion of the nose, throat, and larynx

  • Anterior chest pain is an early symptom of mediastinitis

  • Fulminant stage: Within hours to days, patient progresses to fulminant infection; symptoms or signs of overwhelming sepsis predominate

  • Delirium, obtundation, or findings of meningeal irritation suggest an accompanying hemorrhagic meningitis

Gastrointestinal anthrax

  • Symptoms begin 2–5 days after ingestion of food products contaminated with anthrax spores

  • Fever, diffuse abdominal pain, rebound abdominal tenderness, vomiting, constipation, and diarrhea occur

  • Because the primary lesion is ulcerative, emesis is blood tinged or has coffee-ground appearance; stool may be blood tinged or melenic

  • Bowel perforation can occur

Differential Diagnosis

Cutaneous anthrax

  • Ecthyma gangrenosum

  • Rat-bite fever

  • Ulceroglandular tularemia

  • Plague

  • Glanders

  • Rickettsialpox

  • Orf (parapoxvirus infection)

  • Cutaneous mycobacterial infection

Inhalational anthrax

  • Bacterial mediastinitis

  • Fibrous mediastinitis from

    • Histoplasmosis

    • Coccidioidomycosis

    • Atypical or viral ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.